PMID- 22669506 OWN - NLM STAT- MEDLINE DCOM- 20121119 LR - 20220321 IS - 1432-0584 (Electronic) IS - 0939-5555 (Linking) VI - 91 IP - 10 DP - 2012 Oct TI - Flow cytometric quantification and immunophenotyping of leukemic stem cells in acute myeloid leukemia. PG - 1541-6 LID - 10.1007/s00277-012-1501-7 [doi] AB - Leukemic stem cells (LSCs) are root of clonal growth in acute myeloid leukemia (AML) and responsible for the propagation of leukemic blasts (LBs). LSCs are considered as CD34 + CD38- population among LBs and often express as CD123, CD44, or CD184, which are rarely expressed on normal hematopoietic stem cells and could be the potential therapeutic targets. Using multi-color flow cytometry, we analyzed the proportions of CD34 + CD38- LSCs and expression of CD123, CD44, and CD184 on LSCs in 63 patients with AML. The median proportion of LSCs was 1.3 % (0.0-33.1 %) at the time of diagnosis. Of all patients, 74.6 % of them had CD123-positive LSCs, all patients had CD44-positive LSCs, and 85.7 % had CD184-positive LSCs, respectively. The proportions of LSCs were significantly lower in the complete remission (CR) group compared with non-CR group (P = 0.006). The lower proportions of LSCs in CR group indicated that measurement of the proportion of LSCs might be helpful to predict the prognosis of AML. FAU - Hwang, Keumrock AU - Hwang K AD - Department of Laboratory Medicine, University of Ulsan College of Medicine and Asan Medical Center, 388-1 Pungnap-2dong, Songpa-gu, Seoul 138-736, South Korea. FAU - Park, Chan-Jeoung AU - Park CJ FAU - Jang, Seongsoo AU - Jang S FAU - Chi, Hyun-Sook AU - Chi HS FAU - Kim, Dae-Young AU - Kim DY FAU - Lee, Jung-Hee AU - Lee JH FAU - Lee, Je Hwan AU - Lee JH FAU - Lee, Kyoo Hyung AU - Lee KH FAU - Im, Ho-Joon AU - Im HJ FAU - Seo, Jong-Jin AU - Seo JJ LA - eng PT - Journal Article DEP - 20120606 PL - Germany TA - Ann Hematol JT - Annals of hematology JID - 9107334 SB - IM MH - Adolescent MH - Adult MH - Aged MH - Child MH - Child, Preschool MH - Female MH - Flow Cytometry/*methods MH - Follow-Up Studies MH - Humans MH - Immunophenotyping/*methods MH - Infant MH - Leukemia, Myeloid, Acute/diagnosis/*genetics/*immunology MH - Male MH - Middle Aged MH - Neoplastic Stem Cells/*immunology MH - Young Adult EDAT- 2012/06/07 06:00 MHDA- 2012/12/10 06:00 CRDT- 2012/06/07 06:00 PHST- 2012/02/15 00:00 [received] PHST- 2012/05/22 00:00 [accepted] PHST- 2012/06/07 06:00 [entrez] PHST- 2012/06/07 06:00 [pubmed] PHST- 2012/12/10 06:00 [medline] AID - 10.1007/s00277-012-1501-7 [doi] PST - ppublish SO - Ann Hematol. 2012 Oct;91(10):1541-6. doi: 10.1007/s00277-012-1501-7. Epub 2012 Jun 6.